Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens

被引：0
|
作者：
Susan Swindells
Calvin J Cohen
Daniel S Berger
Karen T Tashima
Qiming Liao
Bonnie F Pobiner
Jerry W Snidow
Gary E Pakes
Jaime E Hernandez
机构：
[1] University of Nebraska Medical Center,HIV Clinic
[2] Community Research Initiative of New England,Infectious Diseases
[3] North Star Medical Center,undefined
[4] Miriam Hospital,undefined
[5] GlaxoSmithKline,undefined
来源：
BMC Infectious Diseases | / 5卷
关键词：
Abacavir; Virologic Failure; Virologic Suppression; Nelfinavir Mesylate; High Hematologic Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [11] Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases
    Ghani, AC
    Henley, WE
    Donnelly, CA
    Mayer, S
    Anderson, RM
    [J]. AIDS, 2001, 15 (09) : 1133 - 1142
  • [12] A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1-Infected Adults With Virologic Suppression on a Protease Inhibitor-Containing Regimen
    Hammer, Scott M.
    Ribaudo, Heather
    Bassett, Roland
    Mellors, John W.
    Demeter, Lisa M.
    Coombs, Robert W.
    Currier, Judith
    Morse, Gene D.
    Gerber, John G.
    Martinez, Ana I.
    Spreen, William
    Fischl, Margaret A.
    Squires, Kathleen E.
    [J]. HIV CLINICAL TRIALS, 2010, 11 (06): : 312 - 324
  • [13] Evolution of genotypic resistance to nucleoside analogues in patients receiving protease inhibitor-containing regimens
    Pèrez-Olmeda, M
    Rubio, A
    Puig, T
    Gômez-Cano, M
    Ruiz, L
    Leal, M
    Clotet, B
    Soriano, V
    [J]. ANTIVIRAL THERAPY, 1999, 4 (03) : 179 - 181
  • [14] Incidence of and risk factors for adverse drug reactions in a prospective cohort of HIV-infected adults initiating protease inhibitor-containing therapy
    Duval, X
    Journot, V
    Leport, C
    Chêne, G
    Dupon, M
    Cuzin, L
    May, T
    Morlat, P
    Waldner, A
    Salamon, R
    Raffi, F
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (02) : 248 - 255
  • [15] Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children
    Buchacz, K
    Cervia, JS
    Lindsey, JC
    Hughes, MD
    Seage, GR
    Dankner, WM
    Oleske, JM
    Moye, J
    [J]. PEDIATRICS, 2001, 108 (04) : E72
  • [16] Natural history of lipid abnormalities and fat redistribution in HIV-infected children receiving long-term protease inhibitor-containing HAART regimens
    Taylor, P
    Worrell, C
    Steinberg, SM
    Hazra, R
    Wood, LV
    Zwerski, S
    Zeichner, S
    [J]. PEDIATRIC RESEARCH, 2004, 55 (04) : 329A - 329A
  • [17] Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use
    Moyle, GJ
    Wilkins, E
    Leen, C
    Cheesbrough, A
    Reynolds, B
    Gazzard, BG
    [J]. AIDS, 2000, 14 (10) : 1453 - 1454
  • [18] Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue
    Ruiz, L
    van Lunzen, J
    Arno, A
    Stellbrink, HJ
    Schneider, C
    Rull, M
    Castellà, E
    Ojanguren, I
    Richman, DD
    Clotet, B
    Tenner-Racz, K
    [J]. AIDS, 1999, 13 (01) : F1 - F8
  • [19] Performance of a quadruple combination including nelfinavir plus efavirenz in naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens
    Barreiro, P
    Oller, V
    Soriano, V
    Nuñez, M
    Rodríguez-Rosado, R
    González-Lahoz, J
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (04) : 391 - 392
  • [20] Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens
    Trotta, MP
    Ammassari, A
    Cozzi-Lepri, A
    Zaccarelli, M
    Castelli, F
    Narciso, P
    Melzi, S
    De Luca, A
    Monforte, AD
    Antinori, A
    [J]. AIDS, 2003, 17 (07) : 1099 - 1102
12345